Dublin, March 08, 2021 (GLOBE NEWSWIRE) -- The "Tissue Processing Systems Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Product, Volume, and End User and Geography" report has been added to ResearchAndMarkets.com's offering.
According to this report the global tissue processing systems market is expected to reach US$ 493.76 million by 2027 from US$ 335.78 million in 2019; it is estimated to grow at a CAGR of 5.1%from 2020 to 2027. The report highlights trends prevailing in the global tissue processing systems market, and the factors governing the market growth.
On the basis of end user, the tissue processing systems market is segmented into hospitals, pharmaceutical companies, research laboratories, and others. The hospitals segment held the largest share of the market in 2019. However, the pharmaceutical companies segment is estimated to register the highest CAGR in the market during the forecast period. Pharmaceutical companies are constant striving to identify new diagnostic and therapeutic methods for treating chronic diseases. Growing biopharmaceutical industry is also likely to favor the growth of the market for this segment. As per the Pharmaceutical Research and Manufacturers Association (PhRMA), US companies conduct more than half of the world's R& D in pharmaceuticals (costing ~US$ 75 billion) and hold the intellectual property rights on most new medicines.
The global tissue processing systems market growth is mainly attributed to as the increasing prevalence of cancer and rising number of diagnostic laboratories. However, the high cost of cancer diagnosis may hinder the market growth.
Agilent Technologies, Inc., Biogenex Laboratories, Sakura FinetekUsa, Inc., Thermo Fisher Scientific Inc., Roche Diagnostics, Siemens Ag, Avantor, Milestone Medical, Leica Biosystems (Danaher Corporation), and Miltenyi Biotec are among the leading companies operating in the tissue processing systems market.
Reasons to Buy:
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the tissue processing systems market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global tissue processing systems market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Key Topics Covered:
1. Introduction
1.1 Scope of the Study
1.2 Report Guidance
1.3 Market Segmentation
1.3.1 Global Tissue Processing Systems Market - By Product
1.3.2 Global Tissue Processing Systems Market - By Volume
1.3.3 Global Tissue Processing Systems Market - By End User
1.3.4 Global Tissue Processing Systems market - By Geography
2. Tissue Processing Systems Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Tissue Processing Systems - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America - PEST Analysis
4.2.2 Europe - PEST Analysis
4.2.3 Asia Pacific - PEST Analysis
4.2.4 Middle East and Africa (MEA) - PEST Analysis
4.2.5 South and Central America (SCAM) - PEST Analysis
4.3 Expert Opinions
5. Tissue Processing Systems Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Cancer
5.1.2 Rising Number of Diagnostic Laboratories
5.2 Market Restraints
5.2.1 High Cost of Cancer Diagnostics
5.3 Market Opportunities
5.3.1 Emerging Markets in Asia Pacific
5.4 Future Trends
5.4.1 Development and Launch of Innovative Products
5.5 Impact Analysis
6. Tissue Processing Systems Market - Global Analysis
6.1 Global Tissue Processing Systems Market Revenue Forecast And Analysis
6.2 Global Tissue Processing Systems Market, By Geography - Forecast And Analysis
6.3 Market Positioning of Key Players
7. Tissue Processing Systems Market Analysis - By Product
7.1 Overview
7.2 Tissue Processing Systems Market Revenue Share, by Product (2019 and 2027)
7.3 Tissue Transfer Processors
7.3.1 Overview
7.3.2 Tissue Transfer Processors: Tissue Processing Systems Market - Revenue and Forecast to 2027 (US$ Million)
7.4 Fluid Transfer Processors
7.4.1 Overview
7.4.2 Fluid Transfer Processors: Tissue Processing Systems Market - Revenue and Forecast to 2027 (US$ Million)
8. Tissue Processing Systems Market Analysis - By Volume
8.1 Overview
8.2 Tissue Processing Systems Market Revenue Share, by Volume (2019 and 2027)
8.3 Small Volume Processors
8.3.1 Overview
8.3.2 Small Volume Processors: Tissue Processing Systems Market - Revenue and Forecast to 2027 (US$ Million)
8.4 Medium Volume Processors
8.4.1 Overview
8.4.2 Medium Volume Processors: Tissue Processing Systems Market - Revenue and Forecast to 2027 (US$ Million)
8.5 Large Volume Processors
8.5.1 Overview
8.5.2 Large Volume Processors: Tissue Processing Systems Market - Revenue and Forecast to 2027 (US$ Million)
9. Tissue Processing Systems Market Analysis - By End User
9.1 Overview
9.2 Tissue Processing Systems Market Share, by End User, 2019 and 2027, (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Tissue Processing Systems Market - Revenue and Forecast to 2027 (US$ Million)
9.4 Pharmaceutical and Biotechnology Companies
9.4.1 Overview
9.4.2 Pharmaceutical and Biotechnology : Tissue Processing Systems Market - Revenue and Forecast to 2027 (US$ Million)
9.5 Research Laboratories
9.5.1 Overview
9.5.2 Research Organizations: Tissue Processing Systems Market - Revenue and Forecast to 2027 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Tissue Processing Systems Market - Revenue and Forecast to 2027 (US$ Million)
10. Tissue Processing Systems Market Revenue and Forecasts to 2027 - Geographical Analysis
10.1 North America Tissue Processing Systems Market Revenue And Forecasts To 2027
10.2 Europe Tissue Processing Systems Market Revenue And Forecasts To 2027
10.3 Asia Pacific: Tissue Processing Systems Market
10.4 Middle East & Africa: Tissue Processing Systems Market
10.5 South and Central America: Tissue Processing Systems Market
11. Impact of COVID-19 Pandemic on Global Tissue Processing System Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Rest of the World: Impact Assessment of COVID-19 Pandemic
12. Tissue processing systems Market - Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
12.3.1 Overview
12.3.2 Developments Done By Companies
12.4 Inorganic Developments
12.4.1 Overview
12.4.2 Inorganic Developments Done By Companies
13. COMPANY PROFILES
13.1 Miltenyi Biotec
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 BioGenex
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Leica Biosystems Nussloch GmbH (Danaher)
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Avantor, Inc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 THERMO FISHER SCIENTIFIC INC.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Siemens AG
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 F. HOFFMANN-LA ROCHE LTD.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Agilent Technologies, Inc.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Milestone Medical
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Sakura Finetek USA, Inc.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
For more information about this report visit https://www.researchandmarkets.com/r/dn58ql